Table 1 Baseline characteristics of study participants tested for SARS-CoV-2 and the association between MGUS and SARS-CoV-2 infection.
From: Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study
No MGUS | MGUS | HC-MGUS | LC-MGUS | |
|---|---|---|---|---|
n | 30,293 | 1754 | 1140 | 614 |
Mean age (SD) | 59 (10) | 66 (11) | 65.9 (11) | 66.9 (11) |
Men | 12,283 (41%) | 880 (50%) | 571 (50%) | 309 (50%) |
Person-years | 24,882 | 1431 | – | – |
SARS-CoV-2-positive | 1035 (3.4%) | 65 (3.7%) | 41 (3.6%) | 24 (3.9%) |
OR of SARS-CoV-2 positivity (95% CI)a | Ref | 1.05 (0.80-1.36) | 1.02 (0.74-1.40) | 1.11 (0.73-1.69) |
